VORICONAZOLE

VORICONAZOLE (10168E)

voriconazole 40 mg/mL powder for oral liquid, 70 mL
10168E
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Prophylaxis of invasive fungal infections including both yeasts and moulds
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $507.72 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vfend

VORICONAZOLE (9452L)

voriconazole 40 mg/mL powder for oral liquid, 70 mL
9452L
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Definite or probable invasive aspergillosis
Treatment phase: Treatment and maintenance therapy

Restriction

Indication: Serious fungal infections
Treatment phase: Treatment and maintenance therapy

Restriction

Indication: Serious Candida infections
Treatment phase: Treatment and maintenance therapy

Restriction

Indication: Serious invasive mycosis infections
Treatment phase: Treatment and maintenance therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $507.72 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Vfend